Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity.
Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity.
复制标题
作者:
Law IK;Xu A;Lam KS;Berger T;Mak TW;Vanhoutte PM;Liu JT;Sweeney G;Zhou M;Yang B;Wang Y
The proinflammatory cytokines/adipokines produced from adipose tissue act in an autocrine and/or endocrine manner to perpetuate local inflammation and to induce peripheral insulin resistance. The present study investigates whether lipocalin-2 deficiency or replenishment with this adipokine has any impact on systemic insulin sensitivity and the underlying mechanisms. Under conditions of aging or dietary-/genetic-induced obesity, lipocalin-2 knockout (Lcn2-KO) mice show significantly decreased fasting glucose and insulin levels and improved insulin sensitivity compared with their wild-type littermates. Despite enlarged fat mass, inflammation and the accumulation of lipid peroxidation products are significantly attenuated in the adipose tissues of Lcn2-KO mice. Adipose fatty acid composition of these mice varies significantly from that in wild-type animals. The amounts of arachidonic acid (C20:4 n6) are elevated by aging and obesity and are paradoxically further increased in adipose tissue, but not skeletal muscle and liver of Lcn2-KO mice. On the other hand, the expression and activity of 12-lipoxygenase, an enzyme responsible for metabolizing arachidonic acid, and the production of tumor necrosis factor-α (TNF-α), a critical insulin resistance–inducing factor, are largely inhibited by lipocalin-2 deficiency. Lipocalin-2 stimulates the expression and activity of 12-lipoxygenase and TNF-α production in fat tissues. Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC), an arachidonate lipoxygenase inhibitor, prevents TNF-α expression induced by lipocalin-2. Moreover, treatment with TNF-α neutralization antibody or CDC significantly attenuated the differences of insulin sensitivity between wild-type and Lcn2-KO mice. Lipocalin-2 deficiency protects mice from developing aging- and obesity-induced insulin resistance largely by modulating 12-lipoxygenase and TNF-α levels in adipose tissue.
登录
查看更多内容
DOI:
10.1016/0167-4889(91)90077-b
发表时间:
1991-10-26
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA
影响因子:
--
作者:
DAVIS, TR;TABATABAI, L;NILSENHAMILTON, M
通讯作者:
NILSENHAMILTON, M
影响因子:
4.4
作者:
Cowland, Jack B.;Muta, Tatsushi;Borregaard, Niels
通讯作者:
Borregaard, Niels
影响因子:
3.5
作者:
Jessen, BA;Stevens, GJ
通讯作者:
Stevens, GJ
DOI:
10.1073/pnas.0510847103
发表时间:
2006-02-07
影响因子:
11.1
作者:
Berger, T;Togawa, A;Mak, TW
通讯作者:
Mak, TW
DOI:
10.1093/gerona/52a.4.b190
发表时间:
1997-07-01
影响因子:
5.1
作者:
Morin, CL;Pagliassotti, MJ;Eckel, RH
通讯作者:
Eckel, RH